[ad_1]
A Chinese vaccine company, which has successfully applied a newly invented coronavirus vaccine to monkeys, now wants to enter experimental use in human bodies worldwide. The name of the vaccine is ‘Picovac’. It is made by Beijing-based company Sinovac Biotech.
Company scientists say the vaccine has been developed following a conventional antiviral process. When applied to the body of an animal, antibodies are produced that help destroy the virus.
According to Bloomberg, after the study results were obtained in mid-April, scientists began testing Picovac on the human body. The vaccine is currently in the third phase of research. Other researchers around the world are working on hundreds of vaccines that are in the first and second stages of research.
“The main challenge is in phase three,” said Ding Zheng, director of the Jinggua University Global Health Drug Discovery Institute in China. This is where the vaccine works in the immune system. ‘
In early March, Chinese researchers applied the recently invented Picovac vaccine to the body of a group of monkeys of the Rhesus macaque species. Three weeks later, the monkeys were exposed to the coronavirus. A week later, the monkeys that were vaccinated were not infected with the crown. And monkeys that have not been vaccinated have coronaviruses in their lungs. Some of them also have pneumonia symptoms.
The Synovac company invented and marketed the SARS vaccine in 2003. Synovac has a reputation for researching and developing vaccines. It remains to be seen how successful their efforts will be in tackling the coronavirus epidemic this time.
So far, two lakh 8,413 people have died of coronavirus worldwide. A total of 40 lakh 26 thousand 547 people have been affected. And 13 lakh 94 thousand 49 people have been able to recover.
[ad_2]
